KALYONCU, U. Et Al. 2021. TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA. EULAR Annual European Congress of Rheumatology,2021 , 69-70.

KALYONCU, U., BİLGİN, E., ERDEN, A., SATIŞ, H., TUFAN, A., TEKGÖZ, E., ... ATEŞ, A.(2021). TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA . EULAR Annual European Congress of Rheumatology,2021 (pp.69-70).

KALYONCU, UMUT Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA," EULAR Annual European Congress of Rheumatology,2021, 2021

KALYONCU, UMUT Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." EULAR Annual European Congress of Rheumatology,2021 , pp.69-70, 2021

KALYONCU, U. Et Al. (2021) . "TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." EULAR Annual European Congress of Rheumatology,2021 , pp.69-70.

@conferencepaper{conferencepaper, author={UMUT KALYONCU Et Al. }, title={TOFACITINIB IN RHEUMATOID ARTHRITIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA}, congress name={EULAR Annual European Congress of Rheumatology,2021}, city={}, country={}, year={2021}, pages={69-70} }